PVG Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

PVG Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-3,384	Closed	-$216K	–	30
2023 Q2	$216K	Sell	3,384 -371	-10%	-$24.9K	0.93%	26
2023 Q1	$260K	Buy	+3,755	New	+$265K	0.83%	22
2020 Q1	$1.36M	Buy	24,340 +327	+1%	+$20K	3.21%	6
2019 Q4	$1.54M	Sell	24,013 -11,968	-33%	-$685K	2.15%	11
2019 Q3	$1.82M	Sell	35,981 -2,091	-5%	-$98.3K	1.98%	15
2019 Q2	$1.73M	Buy	+38,072	New	+$1.77M	1.81%	14
2018 Q4	–	Sell	-9,569	Closed	-$594K	–	62
2018 Q3	$594K	Sell	9,569 -44,806	-82%	-$2.66M	0.43%	55
2018 Q2	$3.01M	Buy	+54,375	New	+$2.94M	1.79%	10

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

PVG Asset Management's BMY Position: Q3 2023 in Review

PVG Asset Management sold out of Bristol-Myers Squibb (BMY) in Q3 2023, closing a stake of 3,384 shares — an estimated $216K sold.

PVG Asset Management first reported a position in BMY in Q2 2018 and held it in 8 quarters. The position peaked at $3.01M in Q2 2018. 2,388 funds tracked by Wall St. Rank hold BMY as of Q3 2023.

PVG Asset Management reported no remaining Bristol-Myers Squibb position as of Q3 2023 after selling out during the quarter.
PVG Asset Management sold 3,384 Bristol-Myers Squibb shares in Q3 2023, an estimated $216K.
PVG Asset Management first reported a position in Bristol-Myers Squibb in Q2 2018 and held it in 8 quarters.
PVG Asset Management's Bristol-Myers Squibb position peaked at $3.01M in Q2 2018.
2,388 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.

Based on PVG Asset Management's 13F filing for Q3 2023, filed 27 Oct 2023.